Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subthalamic stimulation for Parkinson's disease.

A L Benabid1, A Koudsié, A Benazzouz

  • 1Department of Neurosciences, University Hospital of Grenoble, Grenoble, France. alim-louis.benabid@ujf-grenoble.fr

Archives of Medical Research
|October 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Spatial Pattern of Recurrence in Oral Cavity Cancer Treated With Definitive (chemo)radiotherapy: A Tertiary Centre Multidisciplinary Review.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

[Rare case of round cell sarcoma of bone with EWSR1-NFATC2 fusion].

Arkhiv patologii·2025
Same author

Impact of Multiprofessional Radiotherapy Peer Review on Multidisciplinary Team Meeting Staging in Head and Neck Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Expanding healthcare access in rural sub-Saharan Africa.

Perspectives in public health·2024
Same author

Inequality of handwashing practice using antimicrobial agents in Bangladesh: a household level analyses.

Public health·2022
Same author

Occurrence of GI parasites in ruminants of Kashmir and Ladakh.

Journal of parasitic diseases : official organ of the Indian Society for Parasitology·2022

High-frequency stimulation (HFS) of the subthalamic nucleus (STN) effectively inhibits cell activity, significantly reducing Parkinson

Area of Science:

  • Neurosurgery
  • Neuroscience
  • Movement Disorders

Background:

  • Deep brain stimulation (DBS) techniques, including high-frequency stimulation (HFS), have evolved from empirical observations to applications informed by neuroscience research.
  • While HFS has been applied to targets like the thalamus (Vim), its precise mechanism, particularly in the subthalamic nucleus (STN), remains under investigation.
  • Previous research hypothesized HFS in Vim disrupts sensory-motor loops; however, experimental work in rats suggests HFS in the STN functionally inhibits neuronal activity.

Purpose of the Study:

  • To investigate the efficacy and mechanism of high-frequency stimulation (HFS) targeting the subthalamic nucleus (STN) for Parkinson's disease symptoms.
  • To evaluate the clinical outcomes of STN-HFS, focusing on motor symptoms such as rigidity, akinesia, and tremor.
  • To determine the optimal electrode placement for effective STN-HFS based on anatomical and clinical data.

Related Experiment Videos

Main Methods:

  • Stereotactic electrode implantation in the STN under local anesthesia.
  • Utilized ventriculography, MRI, and microelectrode recordings for precise targeting.
  • Clinical assessment of rigidity changes during intraoperative stimulation and evaluation of chronic stimulation effects on motor symptoms.

Main Results:

  • Intraoperative STN stimulation led to a significant decrease in rigidity, as assessed by neurologists.
  • Chronic STN-HFS demonstrated substantial improvement in the cardinal symptoms of Parkinson's disease: akinesia (41.6%), rigidity (48.6%), and tremor (27%).
  • Statistically analyzed optimal electrode contact location for effective stimulation was identified within the STN.

Conclusions:

  • High-frequency stimulation of the subthalamic nucleus (STN-HFS) is a highly effective surgical therapy for advanced Parkinson's disease.
  • The beneficial effects are contingent upon accurate electrode placement within the STN target.
  • STN-HFS offers significant symptom reduction, supporting its consideration as a primary surgical option for advanced Parkinson's disease.